Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.

    Harvard Study Presents an Injectable Vaccine Causing Immunity Against Acute Myeloid Leukemia (AML) in Mice

    According to a recent article in the Harvard Gazette, researchers from Harvard announced the results of a study involving animal models that brought about immunity and lasting recovery against acute…

    Continue Reading Harvard Study Presents an Injectable Vaccine Causing Immunity Against Acute Myeloid Leukemia (AML) in Mice

    The FDA Approves Tukysa™ for Metastatic HER2-Positive Breast Cancer

    Seattle Genetics, Bothell, Washington recently issued an announcement through Drugs.com that the FDA approved Tukysa™ combined with capecitabine and trastuzumab for patients with metastatic HER2-positive breast cancer. The drug combination…

    Continue Reading The FDA Approves Tukysa™ for Metastatic HER2-Positive Breast Cancer

    Seneca Biopharma Preparing for its Phase 3 Trial to Test NSI-566 for Amyotrophic Lateral Sclerosis

    Seneca Biopharma, Germantown, Md., issued a press release announcing its recent meeting with the FDA to discuss elements of a final design and protocol for a Phase 3 trial investigating…

    Continue Reading Seneca Biopharma Preparing for its Phase 3 Trial to Test NSI-566 for Amyotrophic Lateral Sclerosis

    He Waited Five Years to Receive a Kidney Transplant and Then the Kidney Was Given to the Wrong Patient

    According to a report by ABC News, Virtua Health, one of the largest healthcare providers in New Jersey, claimed to have a forty-year history of organ transplant completions. Nonetheless, a…

    Continue Reading He Waited Five Years to Receive a Kidney Transplant and Then the Kidney Was Given to the Wrong Patient
    Parkinson’s Disease:  A New Study Focusing on Preventing the Loss of Dopamine Producing Neurons
    source: pixabay.com

    Parkinson’s Disease:  A New Study Focusing on Preventing the Loss of Dopamine Producing Neurons

      The drug levodopa and most other therapies developed over the years for Parkinson's disease have been centered on correcting the lack of dopamine. Researchers acknowledge that the reason dopamine…

    Continue Reading Parkinson’s Disease:  A New Study Focusing on Preventing the Loss of Dopamine Producing Neurons
    Severe Combined Immunodeficiency: After Quarantine With Their Baby, This Family Was Prepared for Coronavirus
    source: pixabay.com

    Severe Combined Immunodeficiency: After Quarantine With Their Baby, This Family Was Prepared for Coronavirus

      Michael and Armené Kapamajian were at home in Los Angeles settling in with their one week old baby, Sasoun, when their doctor called and asked them to come in…

    Continue Reading Severe Combined Immunodeficiency: After Quarantine With Their Baby, This Family Was Prepared for Coronavirus

    MEDALIST Trial: The Need for Blood Transfusions Was Reduced in Myelodysplastic Syndrome Patients

    Dr. Pierre Fenaux, of Hôpital Saint Louis, Paris and lead author of the MEDALIST trial, told Ash Clinical News that treatment with the investigational drug, luspatercept, improved the rate of…

    Continue Reading MEDALIST Trial: The Need for Blood Transfusions Was Reduced in Myelodysplastic Syndrome Patients

    NIH-funded studies show stents and surgery no better than medication, lifestyle changes at reducing cardiac events

    Researchers find stents, surgery provide higher quality of life for those with chest pain. Invasive procedures such as bypass surgery and stenting—commonly used to treat blocked arteries—are no better at…

    Continue Reading NIH-funded studies show stents and surgery no better than medication, lifestyle changes at reducing cardiac events
    Researchers Have Found an Early Sign of Alzheimer’s Disease in DNA Modification
    source: pixabay.com

    Researchers Have Found an Early Sign of Alzheimer’s Disease in DNA Modification

      In February 2020, Epigenetics published results of a study reporting that researchers have found an early sign of Alzheimer’s disease in DNA modification (methylation) that had been overlooked. Patients…

    Continue Reading Researchers Have Found an Early Sign of Alzheimer’s Disease in DNA Modification

    This Journal Highlights Current Research on Neuromuscular Diseases (NMD)

    In a Special Issue of the journal Disease Models and Mechanisms Highlights, James J. Dowling et al describes pediatric neuromuscular diseases as mostly genetic and affecting areas of the peripheral…

    Continue Reading This Journal Highlights Current Research on Neuromuscular Diseases (NMD)

    Organs-On- A-Chip: A Novel Approach to Studying Inflammatory Bowel Disease

    Biological engineers at MIT are using a new technique to study various organs and their interaction with our immune system. According to a recent article in Science Daily, the researchers…

    Continue Reading Organs-On- A-Chip: A Novel Approach to Studying Inflammatory Bowel Disease

    Using Artificial Intelligence to Study Alzheimer’s and Parkinson’s Disease

    Identifying biomarkers may be an improved method of classifying Alzheimer’s and Parkinson’s. As outlined in a recent article covered by Parkinson's News Today, both diseases are diagnosed for the most…

    Continue Reading Using Artificial Intelligence to Study Alzheimer’s and Parkinson’s Disease
    He Faced Death Multiple Times From iMCD But David Fajgenbaum Will Not Give Up
    source: pixabay.com

    He Faced Death Multiple Times From iMCD But David Fajgenbaum Will Not Give Up

      To celebrate Rare Disease Day and raise awareness for approximately seven thousand rare diseases, Dr. Francis Collins, director of the National Institutes of Health, recently interviewed a person he…

    Continue Reading He Faced Death Multiple Times From iMCD But David Fajgenbaum Will Not Give Up